Feline symmetric dimethylarginine (fSDMA) Test Kit

SDMA comes from the intranuclear methylation of L-arginine residues and is released into the cytoplasm after proteolysis. SDMA is excreted by the kidneys and is a by-product of kidney metabolism. The level of SDMA in the blood can indicate the functional level of the kidneys. Generally, kidney function damage can be detected as early as when 25% of kidney function is lost.

Clinical application:

· Early Nephropathy Screening:

Since fSDMA increases in the early stage of renal function impairment, it is a powerful tool for the early detection of chronic kidney disease. This helps to treat and manage cats before symptoms appear and improve prognosis.

· Monitoring the Progression of Nephropathy:

By regularly determining the level of fSDMA, changes in renal function can be monitored, and the disease progression and treatment effect can be evaluated.

· Evaluating the Impact of Other Diseases on the Kidneys:

fSDMA can also be used to assess the impact of other systemic diseases (such as heart disease, hypertension, diabetes, etc.) on renal function.

· Guiding Treatment:

The fSDMA test results can assist veterinarians in formulating personalized treatment plans, including dietary adjustments, drug therapy, and lifestyle changes.